Cargando…
Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical Trial
Background: Acotiamide is a novel prokinetic drug that acts by enhancing the release of acetylcholine and is used in the treatment of functional dyspepsia-postprandial distress syndrome (FD-PDS). Mosapride is indicated to FD-PDS as per the Rome III treatment guidelines. Mosapride 5 mg three times da...
Autores principales: | Sinha, Shubhadeep, Chary, Sreenivasa, Thakur, Pankaj, Talluri, Leela, Reddy, Mohan, K, Gautam S, Mohan, Jagan M, Jain, Pankaj, Naik, Sunil, C. Reddy, Srinivas V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526522/ https://www.ncbi.nlm.nih.gov/pubmed/34692320 http://dx.doi.org/10.7759/cureus.18109 |
Ejemplares similares
-
Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind, Multicenter Study
por: Sinha, Shubhadeep D, et al.
Publicado: (2021) -
A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder
por: Sinha, Shubhadeep, et al.
Publicado: (2021) -
Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study
por: Sinha, Shubhadeep D, et al.
Publicado: (2021) -
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
por: Matsueda, Kei, et al.
Publicado: (2011) -
Profile of acotiamide in the treatment of functional dyspepsia
por: Ueda, Masahiro, et al.
Publicado: (2016)